Decision means that health care providers in some states will be able to prescribe mifepristone via telemedicine and mail the pills to patients
Experts Address Osteoporosis Therapy and COVID-19 Vaccination
Oral bisphosphonates should be continued without delay; one-week interval recommended between IV bisphosphonate and vaccine
Remdesivir Linked to Faster Clinical Improvement of COVID-19
Findings seen in mainly non-White race/ethnicity patients hospitalized with confirmed SARS-CoV-2 infection
Infliximab May Impede Serologic Response to SARS-CoV-2
Concomitant immunomodulator use further blunted antibody responses to SARS-CoV-2 among infliximab-treated IBD patients
Prescribing of Psychotropic Meds Up in Nursing Homes During COVID-19
Compared with Jan. to Feb. 2020, prescriptions for antipsychotics, antidepressants, trazodone up from March to Sept. 2020
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
FDA Warns Consumers to Not Use Ivermectin for COVID-19
Agency has received reports of patients requiring medical support after self-medicating with ivermectin for use in horses
Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19
No significant improvement seen in median time to resolution of symptoms with ivermectin versus placebo
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Combination Monoclonal Antibody Treatment Authorized for COVID-19
EUA issued for combination of bamlanivimab and etesevimab in patients with mild-to-moderate COVID-19 at high risk for disease progression